RESUME
ARVIND K BANSAL
Educational Qualifications
April 1994 Doctor of Philosophy in Pharmacy from Delhi University on thesis entitled “Development of an Improved Drug Delivery System using Prodrug Approach”
July 1988 Master of Pharmacy (Pharmaceutics) from Delhi University with 71.2 % marks
July 1986 Bachelor of Pharmacy from Delhi University with 71.0 % marks
Additional Qualification
July 2001 One and a half month certificate course in “Introduction to Intellectual Property” conducted by World Intellectual Property Organization (WIPO) Academy, Geneva, Switzerland
Professional profile
Positions held
May, 2008 onwards
Professor and Head, Department of Pharmaceutics, NIPER
June 2003 – April 2008
Associate Professor, Department of Pharmaceutical Technology (Formulations), NIPER
August 2000 – May 2003Assistant Professor, Department of Pharmaceutical Technology (Formulations), NIPER
August 1995 to August 2000 (5 years)
Group Leader at Ranbaxy Research Labs, Gurgaon, Haryana, India
April 1993 to July 1995 (2 years and 4 months)
Research Scientist at JK Pharmaceuticals Shripati Singhania R & D Centre at Faridabad , Haryana.
February 1989 to January 1993
UGC Senior Research Fellow at College of Pharmacy (Delhi University), New Delhi.
Areas of Interest
Pre-formulation Profiling
Biopharmaceutical mapping of salt forms
Solid state characterization
Permeability profiling using Caco 2 cell lines and animal models
Molecular behaviour of powders during compaction
Enhancement of aqueous solubility
Molecular understanding of ‘stabilized’ amorphous forms
Nano-crystalline solid dispersions
Improvement of oral bioavailability - using formulation interventions like lipidic systems, nanoparticles, inclusion complexes etc.
Protein formulations
Interaction with preservatives
Stabilization during lyophilization
Scientific Publications and Presentations
Patent granted / applications – 26
Research papers – 60
Review articles – 16
General articles – 18
Book Chapters – 4
Conference presentations – 36
Selected Publications
1. Srivastava A, Mishra S, Tandon P, Patel S, Ayala AP , Bansal AK and Siesler HW. Moleculat structure and vibrational spectroscopic analysis of an antiplatelet drug; clopidogrel hydrogen sulphate (form 2) – A combined experimental and quantum chemical approach. Journal of Molecular Structure, 2010, 964, 88-96
2. Alam S, Patel S and Bansal AK. Effect of Sample Preparation Method on Quantification of Polymorphs using PXRD. Pharmaceutical Development and Technology, 2010
3. Bora P, Puri V and Bansal AK. Physicochemical Properties and Excipient Compatibility Studies of Probiotic Bacillus coagulans Spores. Scientia Pharmaceutica, 2009, 77(3) 625–637
4. Chawla G, Bansal AK. Molecular Mobility and Physical Stability of Amorphous Irbesartan. Scientia Pharmaceutica, 2009, 77(3) 695–709
5. Sharma SS, Srinivasan SK, Krishnamoorthy S, Kaushal AM and Bansal AK. Preclinical safety Pharmacology studies on the amorphous formulation of celecoxib. Arznemittelforschung, 2009, 59(5), 254-262.
6. Kaushal A, Chakraborti AK and Bansal AK, FTIR Studies on differential intermolecular association in crystalline and amorphous states of structurally related non-steroidal anti-inflammatory drugs, Molecular Pharmaceutics, 2008, 5 (6), 937–945.
7. Bansal SS, Kaushal A and Bansal AK, Co-relationship of Physical stability of amorphous dispersions with enthalpy relaxation. Die Pharmazie, 2008, 63(11), 812-814.
8. Mohammaed GA, Puri V and Bansal AK, Co-processing of nevirapine and stavudine by spray drying. Pharmaceutical Development and Technology, 2008, 13(4), 299-310.
9. Kaushal A and Bansal AK, Thermodynamic behavior of glassy state of structurally related compounds. European Journal of Pharmaceutics and Biopharmaceutics, 2008, 69(3), 1067-1076.
10. Kumar S, Chawla G and Bansal AK. Characterization of solid-state forms of mebendazole. Die Pharmazie, 2008;63(2):136-43.
11. Patel S, Kaushal AM, and Bansal AK, Compaction behavior of roller compacted ibuprofen. Eur J Pharm Biopharm, 2008, 69, 743-749.
12. Patel S, Kaushal AM, and Bansal AK, Lubrication potential of magnesium stearate studied on instrumented rotary tablet press. AAPS PharmSciTech 2007, 8(4), Article 89, E1-E8.
13. Chawla G, and Bansal AK, A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. Eur J Pharm Sci 2007, 32, 45-57.
14. Tiwari M, Chawla G, and Bansal AK, Quantification of olanzapine polymorphs using powder X-ray diffraction technique. J Pharm Biomed Anal 2007, 43 (3), 865-872.
15. Patel S, Kaushal AM, Bansal AK, Effect of particle size and compression force on compaction behavior and derived mathematical parameters of compressibility. Pharm Res 2007, 24(1), 111-124.
16. Banga S, Chawla G, Varandani D, Mehta BR, Bansal AK, Modification of the crystal habit of celecoxib for improved processability. J Pharm Pharmacol 2007, 59(1), 29-39.
17. Rao KP, Chawla G, Kaushal AM, Bansal AK. Impact of solid-state properties on lubrication efficacy of magnesium stearate. Pharm Dev Technol 2005, 10(3), 423-437.
18. Gupta P, Kakumanu VK, Bansal AK. Stability and solubility of celecoxib–PVP amorphous dispersions: a molecular perspective. Pharm Res 2004, 21(10), 1762-1769.
19. Gupta P, Chawla G, Bansal AK. Physical stability and solubility advantage from amorphous celecoxib: The role of thermodynamic quantities and molecular mobility. Mol Pharm 2004, 1(6), 406-413.
20. Chawla G, Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. Characterization of solid–state forms of celecoxib. Eur J Pharm Sci 2003, 20(3), 305–317.
Industrial Consultancy Projects
More than 125 projects completed with overseas and Indian pharmaceutical companies.
Awards and Honors
AAiPS Distinguished Educator and Researcher Award for the Year 2008
This award is given to a faculty member from a recognized Indian Pharmacy education and research center. The mission of American Association of Indian Pharmaceutical Scientists (AAiPS) is to provide a forum for discussion, continuing education, and exchange of ideas on advances in pharmaceutical sciences and technology.
Innocentive award, in the area of formulation development - April 2005, May 2006 and June 2007.
Innocentive (www.innocentive.com) is a web-based community, managed by a sister concern of Eli Lilly,USA and facilitates pharmaceutical scientists to address challenges faced by chemical and pharmaceutical companies, from around the globe.
OPPI (Organization of Pharmaceutical Producers of India (OPPI) Scientist Award 2006
This award was conferred in September 2006, for outstanding contribution in the area of Pharmaceutics. The OPPI, established in 1965, is a premier organization of pharmaceutical manufacturers in India. Its membership consists of companies with international collaboration and large Indian companies. It represents primarily research based companies in India. OPPI is not only an industry association but also a scientific and professional body.
E Mail Address
akbansal@niper.ac.in
